ADmit Therapeutics
Founded 2017 · $6.5M raised
- Founded
- 2017
- Business Model
- B2B
- Website
- admit-therapeutics.com
- Total Funding
- $6.5M
- Last Round
- $6.3M Series AOct 2023
- Rounds
- 2
About
Methylation profiling diagnostic for early Alzheimer's diagnosis.
Summary
ADmit Therapeutics is a Biotech company, founded in 2017. It has raised $6.5M in total across 2 rounds, most recently a $6.3M Series A round in Oct 2023. Investors include European Innovation Council Fund, Alzheimer's Drug Discovery Foundation and StartUp Health.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company